While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults.

Just one in four (25%) people at high risk of pneumococcal disease, an infection that causes pneumonia—children younger than 2, adults older than 64, and those with certain chronic health ...

The CDC revised its pneumococcal pneumonia shot recommendation, saying there is a substantial increase in the risk for ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

MSD’s current jab Vaxneuvance – which covers 15 serotypes – is also approved for use in infants, children ... used to prevent invasive pneumococcal disease (IPD) in this group.